Taro recalls 17k antifungal shampoo

Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA). According to its latest Enforcement Report, the US health regulator stated that Hawthorne-based Sun Pharma/ Taro is recalling 17,664 units of Ciclopirox Shampoo, an antifungal medication that treats seborrheic dermatitis, a condition that causes dry, flaky, and itchy skin. The company is recalling the affected lot due to "Failed Impurity/Degradation specifications," the USFDA stated. The company initiated the Class II nationwide recall on December 9 this year.